Bioaerosols (aerosolized particles with biological origin) are strongly suspected to play a significant role in the transmission of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2), especially in closed indoor environments. Thus, control technologies capable of effectively inactivating bioaerosols are urgently needed. In this regard, cold atmospheric pressure plasma (CAP) can represent a suitable option, thanks to its ability to produce reactive species, which can exert antimicrobial action. In this study, results; on the total inactivation of SARS-CoV-2 contained in bioaerosols treated using CAP generated in air are reported, demonstrating the possible use of CAP systems for the control of SARS-CoV-2 diffusion through bioaerosols.

Cold atmospheric plasma decontamination of SARS-CoV-2 bioaerosols / Bisag A.; Isabelli P.; Laghi G.; Laurita R.; Dirani G.; Taddei F.; Bucci C.; Capelli F.; Gherardi M.; Paglianti A.; Sambri V.; Colombo V.. - In: PLASMA PROCESSES AND POLYMERS. - ISSN 1612-8850. - ELETTRONICO. - 19:3(2022), pp. e2100133.1-e2100133.11. [10.1002/ppap.202100133]

Cold atmospheric plasma decontamination of SARS-CoV-2 bioaerosols

Bisag A.;Isabelli P.;Laghi G.;Laurita R.;Dirani G.;Bucci C.;Capelli F.;Gherardi M.;Paglianti A.;Sambri V.;Colombo V.
2022

Abstract

Bioaerosols (aerosolized particles with biological origin) are strongly suspected to play a significant role in the transmission of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2), especially in closed indoor environments. Thus, control technologies capable of effectively inactivating bioaerosols are urgently needed. In this regard, cold atmospheric pressure plasma (CAP) can represent a suitable option, thanks to its ability to produce reactive species, which can exert antimicrobial action. In this study, results; on the total inactivation of SARS-CoV-2 contained in bioaerosols treated using CAP generated in air are reported, demonstrating the possible use of CAP systems for the control of SARS-CoV-2 diffusion through bioaerosols.
2022
Cold atmospheric plasma decontamination of SARS-CoV-2 bioaerosols / Bisag A.; Isabelli P.; Laghi G.; Laurita R.; Dirani G.; Taddei F.; Bucci C.; Capelli F.; Gherardi M.; Paglianti A.; Sambri V.; Colombo V.. - In: PLASMA PROCESSES AND POLYMERS. - ISSN 1612-8850. - ELETTRONICO. - 19:3(2022), pp. e2100133.1-e2100133.11. [10.1002/ppap.202100133]
Bisag A.; Isabelli P.; Laghi G.; Laurita R.; Dirani G.; Taddei F.; Bucci C.; Capelli F.; Gherardi M.; Paglianti A.; Sambri V.; Colombo V.
File in questo prodotto:
File Dimensione Formato  
Plasma Processes Polymers - 2021 - Bisag - Cold atmospheric plasma decontamination of SARS‐CoV‐2 bioaerosols.pdf

accesso aperto

Tipo: Versione (PDF) editoriale
Licenza: Licenza per Accesso Aperto. Creative Commons Attribuzione (CCBY)
Dimensione 1.65 MB
Formato Adobe PDF
1.65 MB Adobe PDF Visualizza/Apri

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/11585/865699
Citazioni
  • ???jsp.display-item.citation.pmc??? ND
  • Scopus 11
  • ???jsp.display-item.citation.isi??? 12
social impact